Literature DB >> 10527633

EGFR family-mediated signal transduction in the human keratinocyte cell line HaCaT.

M M Marqués1, N Martínez, I Rodríguez-García, A Alonso.   

Abstract

We analyzed the formation of homo- and heterodimers between EGFR, ErbB2, and ErbB3 (members of the EGF receptor family) in the human skin keratinocyte cell line HaCaT, in dependence of the added ligand. ErbB4 was not unambiguously identified. By immunoprecipitation and Western blots, we showed the formation of heterodimers between all members of the family. Whereas EGF and TGF-alpha strongly induced heterodimerization, no effect was observed with heregulin. At the concentrations used all ligands elicited a similar, differentiation-independent activation of erk1/2 MAP kinase, with the exception of heregulin which activated p42/44 only marginally. We also found that different ligands triggered different transcription patterns of "early genes," with the exception of heregulin which did not modulate transcription. TGF-alpha was the most efficient ligand in promoting incorporation of tritiated thymidine into the DNA. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527633     DOI: 10.1006/excr.1999.4634

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth.

Authors:  Stefan W Stoll; Jessica L Johnson; Yong Li; Laure Rittié; James T Elder
Journal:  J Invest Dermatol       Date:  2010-04-29       Impact factor: 8.551

2.  Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.

Authors:  S W Stoll; S Kansra; S Peshick; D W Fry; W R Leopold; J F Wiesen; M Sibilia; T Zhang; Z Werb; R Derynck; E F Wagner; J T Elder
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

Review 3.  Roles for neuregulins in human cancer.

Authors:  Christophe Stove; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing?

Authors:  Antonio Di Grazia; Floriana Cappiello; Akiko Imanishi; Arianna Mastrofrancesco; Mauro Picardo; Ralf Paus; Maria Luisa Mangoni
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

5.  Design and evaluation of a peptide-based immunotoxin for breast cancer therapeutics.

Authors:  Kelsey J Weigel; Luqun Shen; Clayton L Thomas; Daniel Alber; Lauren Drapalik; Zachary T Schafer; Shaun W Lee
Journal:  FEBS Open Bio       Date:  2015-03-14       Impact factor: 2.693

6.  Epidermal growth factor receptor transactivation is required for mitogen-activated protein kinase activation by muscarinic acetylcholine receptors in HaCaT keratinocytes.

Authors:  Wymke Ockenga; Sina Kühne; Simone Bocksberger; Antje Banning; Ritva Tikkanen
Journal:  Int J Mol Sci       Date:  2014-11-21       Impact factor: 5.923

7.  Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies.

Authors:  I Laux; A Jain; S Singh; D B Agus
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

8.  Oscillations of ultra-weak photon emission from cancer and non-cancer cells stressed by culture medium change and TNF-α.

Authors:  Pierre Madl; Thomas Verwanger; Mark Geppert; Felix Scholkmann
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

9.  Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists.

Authors:  Shawn G Kwatra; Emily Boozalis; Amy H Huang; Cory Nanni; Raveena Khanna; Kyle A Williams; Yevgeniy R Semenov; Callie M Roberts; Robert F Burns; Madison Krischak; Madan M Kwatra
Journal:  Medicines (Basel)       Date:  2019-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.